Efficacy and safety of dapagliflozin according to frailty in patients with heart failure: a prespecified analysis of the DELIVER Trial
Butt JH, Jhund PS, Belohlávek J, et al.
Circulation. 2022;146(16):1210-1224.
Leggi
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Butt JH, Jhund PS, Belohlávek J, et al.
Circulation. 2022;146(16):1210-1224.
Leggi
Okoroike H, Patel S, Simone P, et al.
The American Journal of Cardiology. Pub. online 22 Oct 2022.
Leggi
Volke V, Katus U, Johannson A, et al.
BMC Endocr Disord. 2022;22(1):251.
Leggi
Ke C, Lipscombe LL, Weisman A, et al.
JAMA. Pub. online 14 Oct 2022.
Leggi
Boje AS, Sørensen MH, Gæde P, Madsen PL
Diabetes Care. 2022;dc220942.
Leggi
Lin T, Manfredo JA, Illesca N, et al.
Diabetes Technol Ther. Pub. online 12 Oct 2022.
Leggi
Mutie PM, Pomares-Milan H, Atabaki-Pasdar N, et al.
Diabetologia. Pub. online 12 Oct 2022.
Leggi
Forst T, Mathieu C, Giorgino F, et al.
BMC Med. 2022;20(1):337.
Leggi
Rifai MA, Szklo M, Patel J, et al.
Am J Cardiol. 2022;S0002-9149(22)00958-4.
Leggi
Ørskov M, Vorum H , Bjerregaard Larsen T, et al.
Am J Med. 2022;S0002-9343(22)00723-9.
Leggi